| National Seating & Mobility, Inc. | |
| 2222 Simpson Ave, Aberdeen, Washington 98520 | |
| (360) 532-2222 |
| Name | National Seating & Mobility, Inc. |
|---|---|
| Organization Name | National Seating & Mobility, Inc. |
| Location | 2222 Simpson Ave, Aberdeen, Washington 98520 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (360) 532-2222 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
PNP Therapeutics, Inc. — an early-stage Birmingham-based biopharmaceutical company created from research conducted at Southern Research Institute and The University of Alabama at Birmingham — today announced that several major objectives have been reached in the development of its therapeutic technology platform and proprietary products for the treatment of cancer.
Nanyang Technological University is giving the development of nanotechnology a big boost, by establishing a new $60 million research institute in Nanomedicine, which focuses on the medical application of nanotechnology. An emerging field in drugs, nanomedicine are made up of tiny nano-sized particles thousands of times smaller than a grain of sand.
A clinical research study to develop a rapid and inexpensive blood screening test for the early diagnosis of pancreatic cancer has been launched by Henry Ford Health System and the Barbara Ann Karmanos Cancer Institute.
Scientists have identified a gene which could help predict whether a breast cancer patient will respond to taking tamoxifen. The study, published in the British Journal of Cancer today (Wednesday), showed a potential link between the activity of a gene called BCAR4 and the likelihood that a breast cancer tumour will not respond to tamoxifen - widely used to treat women with breast cancer.
› Verified 3 days ago
| NPI Number | 1154455830 |
| Organization Name | AARO MEDICAL SUPPLIES INC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2222 Simpson Ave, Aberdeen, WA 98520 |
| Phone Number | 360-532-2222 |
News Archive
PNP Therapeutics, Inc. — an early-stage Birmingham-based biopharmaceutical company created from research conducted at Southern Research Institute and The University of Alabama at Birmingham — today announced that several major objectives have been reached in the development of its therapeutic technology platform and proprietary products for the treatment of cancer.
Nanyang Technological University is giving the development of nanotechnology a big boost, by establishing a new $60 million research institute in Nanomedicine, which focuses on the medical application of nanotechnology. An emerging field in drugs, nanomedicine are made up of tiny nano-sized particles thousands of times smaller than a grain of sand.
A clinical research study to develop a rapid and inexpensive blood screening test for the early diagnosis of pancreatic cancer has been launched by Henry Ford Health System and the Barbara Ann Karmanos Cancer Institute.
Scientists have identified a gene which could help predict whether a breast cancer patient will respond to taking tamoxifen. The study, published in the British Journal of Cancer today (Wednesday), showed a potential link between the activity of a gene called BCAR4 and the likelihood that a breast cancer tumour will not respond to tamoxifen - widely used to treat women with breast cancer.
› Verified 3 days ago
| NPI Number | 1184259772 |
| Organization Name | NATIONAL SEATING & MOBILITY, INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2222 Simpson Ave, Aberdeen, WA 98520 |
| Phone Number | 360-532-2222 |
News Archive
PNP Therapeutics, Inc. — an early-stage Birmingham-based biopharmaceutical company created from research conducted at Southern Research Institute and The University of Alabama at Birmingham — today announced that several major objectives have been reached in the development of its therapeutic technology platform and proprietary products for the treatment of cancer.
Nanyang Technological University is giving the development of nanotechnology a big boost, by establishing a new $60 million research institute in Nanomedicine, which focuses on the medical application of nanotechnology. An emerging field in drugs, nanomedicine are made up of tiny nano-sized particles thousands of times smaller than a grain of sand.
A clinical research study to develop a rapid and inexpensive blood screening test for the early diagnosis of pancreatic cancer has been launched by Henry Ford Health System and the Barbara Ann Karmanos Cancer Institute.
Scientists have identified a gene which could help predict whether a breast cancer patient will respond to taking tamoxifen. The study, published in the British Journal of Cancer today (Wednesday), showed a potential link between the activity of a gene called BCAR4 and the likelihood that a breast cancer tumour will not respond to tamoxifen - widely used to treat women with breast cancer.
› Verified 3 days ago
News Archive
PNP Therapeutics, Inc. — an early-stage Birmingham-based biopharmaceutical company created from research conducted at Southern Research Institute and The University of Alabama at Birmingham — today announced that several major objectives have been reached in the development of its therapeutic technology platform and proprietary products for the treatment of cancer.
Nanyang Technological University is giving the development of nanotechnology a big boost, by establishing a new $60 million research institute in Nanomedicine, which focuses on the medical application of nanotechnology. An emerging field in drugs, nanomedicine are made up of tiny nano-sized particles thousands of times smaller than a grain of sand.
A clinical research study to develop a rapid and inexpensive blood screening test for the early diagnosis of pancreatic cancer has been launched by Henry Ford Health System and the Barbara Ann Karmanos Cancer Institute.
Scientists have identified a gene which could help predict whether a breast cancer patient will respond to taking tamoxifen. The study, published in the British Journal of Cancer today (Wednesday), showed a potential link between the activity of a gene called BCAR4 and the likelihood that a breast cancer tumour will not respond to tamoxifen - widely used to treat women with breast cancer.
› Verified 3 days ago
Rite Aid Pharmacy 05282 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 301 E Wishkah St, Aberdeen, Washington 98520 Phone: (360) 533-6320 | |
Lincare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 722 W 2nd St, Aberdeen, Washington 98520 Phone: (360) 532-5287 | |
Safeway Pharmacy #1546 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 221 W Heron St, Aberdeen, Washington 98520 Phone: (360) 532-8743 | |
Wal Mart Pharmacy 10-2037 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 909 E Wishkah St, Aberdeen, Washington 98520 Phone: (360) 532-7875 | |
City Center Drug Inc Type: Long Term Care Pharmacy Location: 108 E Wishkah St, Aberdeen, Washington 98520 Phone: (360) 532-5182 |